However, in the case of tirzepatide, although discontinuation rates are similarly high, the relative rates of cancer remained largely consistent between the primary and sensitivity analyses— though they did not reach statistical significance. 32 The second possible explanation for the discrepancy in findings between the primary and sensitivity analyses could be that the results are affected by reverse causality.
← all excerpts
Weight loss interventions and obesity-associated cancers in people with type 2 diabetes and overweight/obesity: A real-world observational study.
1
—
—